REMSleep Holdings, Inc. (RMSL)
USD 0.01
(-6.25%)
USD 0.01
(-6.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.66 Million USD | -44.32% |
| 2022 | -1.17 Million USD | -6.55% |
| 2021 | -368.12 Thousand USD | -40.7% |
| 2020 | -514.76 Thousand USD | 80.31% |
| 2019 | -3.45 Million USD | -1092.0% |
| 2018 | -352.81 Thousand USD | 49.19% |
| 2017 | -647.1 Thousand USD | -229.86% |
| 2016 | -196.17 Thousand USD | -129.56% |
| 2015 | -85.45 Thousand USD | 77.57% |
| 2014 | -82.6 Thousand USD | 74.05% |
| 2013 | -1.74 Million USD | -109.99% |
| 2012 | -2.27 Million USD | -21.78% |
| 2011 | -875.91 Thousand USD | -83.22% |
| 2010 | -728.05 Thousand USD | 469879.5% |
| 2009 | -23.83 Thousand USD | 27.94% |
| 2008 | -33.07 Thousand USD | 12.49% |
| 2007 | -37.79 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -96.66 Thousand USD | 80.67% |
| 2024 Q2 | -270.78 Thousand USD | 15.46% |
| 2023 Q3 | -255.19 Thousand USD | -31.23% |
| 2023 FY | - USD | -44.32% |
| 2023 Q4 | -1.01 Million USD | -299.54% |
| 2023 Q1 | -200.2 Thousand USD | 49.66% |
| 2023 Q2 | -194.45 Thousand USD | 2.87% |
| 2022 Q1 | -138.02 Thousand USD | 31.96% |
| 2022 FY | - USD | -6.55% |
| 2022 Q4 | -397.69 Thousand USD | -35.22% |
| 2022 Q3 | -294.11 Thousand USD | 10.04% |
| 2022 Q2 | -326.95 Thousand USD | -136.88% |
| 2021 Q1 | -292 Thousand USD | -15.29% |
| 2021 Q3 | -577.04 Thousand USD | 72.66% |
| 2021 Q4 | -202.87 Thousand USD | 64.84% |
| 2021 FY | - USD | -40.7% |
| 2021 Q2 | -2.11 Million USD | -622.83% |
| 2020 FY | - USD | 80.31% |
| 2020 Q1 | -101.76 Thousand USD | 85.89% |
| 2020 Q2 | 193.53 Thousand USD | 290.18% |
| 2020 Q3 | -130.81 Thousand USD | -167.59% |
| 2020 Q4 | -253.27 Thousand USD | -93.61% |
| 2019 FY | - USD | -1092.0% |
| 2019 Q4 | -721.46 Thousand USD | -1329.91% |
| 2019 Q3 | 58.66 Thousand USD | 102.58% |
| 2019 Q1 | -174.17 Thousand USD | -142.38% |
| 2019 Q2 | -2.27 Million USD | -1206.48% |
| 2018 Q3 | -289.26 Thousand USD | 5.61% |
| 2018 Q2 | -306.47 Thousand USD | -90.37% |
| 2018 Q1 | -160.98 Thousand USD | 64.18% |
| 2018 FY | - USD | 49.19% |
| 2018 Q4 | 411.01 Thousand USD | 242.09% |
| 2017 Q4 | -449.49 Thousand USD | -909.68% |
| 2017 Q3 | -44.51 Thousand USD | 88.55% |
| 2017 Q2 | -388.83 Thousand USD | 6.18% |
| 2017 Q1 | -414.43 Thousand USD | -148.05% |
| 2017 FY | - USD | -229.86% |
| 2016 Q4 | -167.07 Thousand USD | -1392200.0% |
| 2016 Q1 | -26.03 Thousand USD | -12.49% |
| 2016 Q2 | -3000.00 USD | 88.48% |
| 2016 Q3 | -12.00 USD | 99.6% |
| 2016 FY | - USD | -129.56% |
| 2015 Q1 | -13.93 Thousand USD | -248.06% |
| 2015 FY | - USD | 77.57% |
| 2015 Q4 | -23.14 Thousand USD | -9961.3% |
| 2015 Q3 | -230.00 USD | 99.4% |
| 2015 Q2 | -38.38 Thousand USD | -175.47% |
| 2014 FY | - USD | 74.05% |
| 2014 Q4 | 9411.00 USD | 109.2% |
| 2014 Q3 | -102.3 Thousand USD | 60.12% |
| 2014 Q2 | -256.5 Thousand USD | -38.07% |
| 2014 Q1 | -185.78 Thousand USD | 78.03% |
| 2013 FY | - USD | -109.99% |
| 2013 Q1 | -206.28 Thousand USD | 83.42% |
| 2013 Q2 | -798.38 Thousand USD | -287.03% |
| 2013 Q3 | -202.06 Thousand USD | 74.69% |
| 2013 Q4 | -845.62 Thousand USD | -318.48% |
| 2012 Q4 | -1.24 Million USD | -2173.43% |
| 2012 FY | - USD | -21.78% |
| 2012 Q1 | -17.25 Thousand USD | -100.09% |
| 2012 Q2 | 16.05 Million USD | 93150.74% |
| 2012 Q3 | -54.72 Thousand USD | -100.34% |
| 2011 FY | - USD | -83.22% |
| 2011 Q3 | - USD | 100.0% |
| 2011 Q2 | -69.18 Thousand USD | -262.98% |
| 2011 Q1 | -19.06 Thousand USD | 89.63% |
| 2011 Q4 | 18.87 Million USD | 0.0% |
| 2010 Q4 | -183.79 Thousand USD | 44.57% |
| 2010 Q3 | -331.56 Thousand USD | -55.88% |
| 2010 Q2 | -212.69 Thousand USD | -6599.18% |
| 2010 Q1 | -3175.00 USD | -638.14% |
| 2010 FY | - USD | 469879.5% |
| 2009 Q1 | -12.9 Thousand USD | -282.98% |
| 2009 Q2 | -11.32 Thousand USD | 12.21% |
| 2009 Q4 | 590.00 USD | 395.0% |
| 2009 Q3 | -200.00 USD | 98.23% |
| 2009 FY | - USD | 27.94% |
| 2008 Q1 | -6500.00 USD | 16.63% |
| 2008 Q4 | 7050.00 USD | 217.5% |
| 2008 Q3 | -6000.00 USD | 79.04% |
| 2008 FY | - USD | 12.49% |
| 2008 Q2 | -28.62 Thousand USD | -340.38% |
| 2007 Q3 | -275.00 USD | 0.0% |
| 2007 Q4 | -7797.00 USD | -2735.27% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -508.317% |
| IR-Med Inc. | -4.89 Million USD | 65.892% |
| Polarean Imaging plc | -11.19 Million USD | 85.096% |
| Medical Supply International USA, Inc. | 456.06 Thousand USD | 465.863% |
| Avitar, Inc. | -1.66 Million USD | -0.045% |
| AVITA Medical, Inc. | -39.56 Million USD | 95.783% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -43.347% |
| Össur hf. | 137.38 Million USD | 101.215% |
| Zecotek Photonics Inc. | -3.44 Million USD | 51.527% |
| QHSLab, Inc. | -91.29 Thousand USD | -1727.691% |
| Wellstar International, Inc. | -1.35 Million USD | -23.003% |
| Össur hf. | 137.38 Million USD | 101.215% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 9.77 Million USD | 117.071% |
| Escalon Medical Corp. | -58.46 Thousand USD | -2754.132% |
| Aurora Spine Corporation | -454.37 Thousand USD | -267.217% |
| BrainsWay Ltd. | -2.31 Million USD | 27.799% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -9.37 Million USD | 82.21% |
| Hamilton Thorne Ltd. | 5.52 Million USD | 130.219% |
| Vivos Inc. | -2.79 Million USD | 40.263% |
| MicroPort Scientific Corporation | -347.57 Million USD | 99.52% |
| Kelyniam Global, Inc. | -197.69 Thousand USD | -744.021% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -340.361% |
| Nanomix Corporation | -8.13 Million USD | 79.501% |
| Theraclion SA | -2.05 Million USD | 18.638% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -707.03 Thousand USD | -135.995% |
| Positron Corporation | -1.45 Million USD | -14.902% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -1.72 Million USD | 3.097% |
| Lombard Medical, Inc. | -28.06 Million USD | 94.055% |
| ALR Technologies Inc. | -6.4 Million USD | 73.93% |
| Stratec SE | 39.91 Million USD | 104.18% |
| Vycor Medical, Inc. | 100.94 Thousand USD | 1752.967% |
| Heart Tronics, Inc. | -14.85 Million USD | 88.769% |
| Nu-Med Plus, Inc. | -118.25 Thousand USD | -1310.932% |
| Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 87.433% |
| SANUWAVE Health, Inc. | -9.15 Million USD | 81.768% |
| VMS Rehab Systems, Inc. | -68.55 USD | -2433968.563% |
| Guided Therapeutics, Inc. | -3.12 Million USD | 46.623% |
| Ingen Technologies, Inc. | -8639.00 USD | -19214.203% |
| Odyssey Group International, Inc. | -2.13 Million USD | 21.96% |
| United American Healthcare Corporation | -59 Thousand USD | -2728.058% |
| ECGI Holdings, Inc. | -2.99 Million USD | 44.204% |
| Capital Group Holdings, Inc. | -629.18 Thousand USD | -165.194% |
| ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -224.606% |
| Urologix, Inc. | -6.34 Million USD | 73.699% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -34.63% |
| Nexeon MedSystems Inc. | -765.96 Thousand USD | -117.836% |
| SS Innovations International, Inc. | -20.37 Million USD | 91.811% |
| Qualis Innovations, Inc. | -222.81 Thousand USD | -648.842% |
| Smith & Nephew plc | 1 Billion USD | 100.166% |
| NIOX Group Plc | 11.07 Million USD | 115.066% |
| Fuse Medical, Inc. | 1.83 Million USD | 190.914% |
| Broncus Holding Corporation | -25.19 Million USD | 93.378% |
| Brain Scientific Inc. | -7.93 Million USD | 78.969% |
| Pressure BioSciences, Inc. | -9.39 Million USD | 82.232% |
| Health Logic Interactive Inc. | -18.4 Thousand USD | -8968.228% |